Ontario chooses Shopify to run online cannabis sales

The Ontario government has inked a deal to use Shopify Inc.'s e-commerce platform for cannabis sales online and in stores as part of its plan to be the province's sole distributor of legal recreational marijuana.

Harvest One Announces Capacity Targets and Facility Updates

Harvest One Cannabis Inc. (TSXV:HVT) through its wholly-owned subsidiary United Greeneries is pleased to announce its expansion targets of 20,000kg dried cannabis flower capacity by YE 2018 and 70,000kg dried flower capacity by YE 2019 which is anticipated to be fully funded by the Company's existing cash position of approximately $80m.

Aurora Cannabis and CanniMed Therapeutics File Offer Documents for Previously Announced Friendly Acquisition

Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CanniMed Therapeutics Inc. (TSX: CMED) today announced the filing of Aurora's Notice of Variation and CanniMed's Notice of Change to Directors' Circular in connection with Aurora's improved offer to acquire all of the outstanding common shares of CanniMed not already owned by Aurora or its affiliates

Medical marijuana bill passes Virginia Senate 40-0

The Virginia Senate voted unanimously Monday to pass the Joint Commission on Health Care bill SB 726, which will let Virginia doctors recommend the use of cannabidiol oil or THC-A oil for the treatment of any diagnosed condition or disease.

Aphria and Liberty Health Sciences Announce Definitive Agreement for Sale of Aphria's Investment in Copperstate Farms to Liberty

Aphria Inc. (TSX: APH or OTCQB: APHQF) and Liberty Health Sciences Inc. (CSE:LHS or OTCQB:LHSIF) jointly announce that they have entered into a definitive agreement with respect to the sale of Aphria's subsidiary Aphria Inc. and its sole holdings being the minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC to Liberty for a purchase price of $20 million.

Eyechronic Receives $3 Million in Funding From Tuatara Capital

Eyechronic, a leading marketing platform for cannabis dispensaries and brands, today announced it secured $3 million in Series A funding from Tuatara Capital, L.P., a specialized alternative investment manager focused on supporting high-growth companies in the legal cannabis industry.